ImpediMed Limited
IPDQF
$0.01
$0.00-17.65%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.47M | 2.46M | 2.15M | 2.11M | 1.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.47M | 2.46M | 2.15M | 2.11M | 1.96M |
| Cost of Revenue | 308.50K | 307.50K | 330.50K | 323.70K | 233.60K |
| Gross Profit | 2.16M | 2.15M | 1.82M | 1.78M | 1.72M |
| SG&A Expenses | 4.39M | 4.38M | 3.99M | 3.91M | 4.18M |
| Depreciation & Amortization | 692.10K | 689.90K | 754.90K | 739.30K | 719.10K |
| Other Operating Expenses | 614.00K | 612.10K | 689.90K | 675.60K | 576.40K |
| Total Operating Expenses | 6.03M | 6.01M | 5.81M | 5.69M | 5.73M |
| Operating Income | -3.57M | -3.55M | -3.66M | -3.58M | -3.77M |
| Income Before Tax | -4.03M | -4.01M | -3.87M | -3.79M | -3.63M |
| Income Tax Expenses | 4.60K | 4.60K | 4.80K | 4.70K | 3.60K |
| Earnings from Continuing Operations | -4.03M | -4.02M | -3.87M | -3.79M | -3.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.03M | -4.02M | -3.87M | -3.79M | -3.63M |
| EBIT | -3.57M | -3.55M | -3.66M | -3.58M | -3.77M |
| EBITDA | -2.87M | -2.86M | -3.62M | -3.33M | -3.05M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.03B | 2.03B | 2.02B | 2.02B | 2.02B |
| Average Diluted Shares Outstanding | 2.03B | 2.03B | 2.02B | 2.02B | 2.02B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |